Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides,
申请人:Hoechst Aktiengesellschaft
公开号:US05494911A1
公开(公告)日:1996-02-27
Isoxazole-4-carboxamide derivatives and hydroxyalkylidene-cyanoacetamide derivatives are suitable for the treatment of carcinoses. These compounds can be prepared by known processes. Some of the compounds are novel and are additionally suitable for the treatment of rheumatic disorders.